Predictors of depression, anxiety and quality of life in patients with prostate cancer receiving androgen deprivation therapy

Kelly Maree Chipperfield; Jane Madeline Fletcher; Jeremy Millar; Joanne Elizabeth Brooker; Robin Smith; Mark Frydenberg; Susan Burney

doi:10.1002/pon.3269

Predictors of depression, anxiety and quality of life in patients with prostate cancer receiving androgen deprivation therapy

Kelly Maree Chipperfield, Jane Madeline Fletcher, Jeremy Millar, Joanne Elizabeth Brooker, Robin Smith, Mark Frydenberg, Susan Burney

Research output: Contribution to journal › Article › Research › peer-review

44 Citations (Scopus)

Abstract

To evaluate the effects of androgen deprivation therapy (ADT) on depression, anxiety and quality of life (QoL) in patients with prostate cancer (PCa) and to examine the relationship between meeting the National Physical Activity Guidelines of Australia (NPAGA) and the presence and severity of both psychological sequelae and physical side effects associated with ADT. A secondary purpose was to examine the predictors of depression, anxiety and QoL in patients with PCa.

Original language	English
Pages (from-to)	2169 - 2176
Number of pages	8
Journal	Psycho-Oncology
Volume	22
Issue number	10
DOIs	https://doi.org/10.1002/pon.3269
Publication status	Published - 2013

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1002/pon.3269

Cite this

@article{e038c1605c4841d9b14b348ae610bf2e,

title = "Predictors of depression, anxiety and quality of life in patients with prostate cancer receiving androgen deprivation therapy",

abstract = "To evaluate the effects of androgen deprivation therapy (ADT) on depression, anxiety and quality of life (QoL) in patients with prostate cancer (PCa) and to examine the relationship between meeting the National Physical Activity Guidelines of Australia (NPAGA) and the presence and severity of both psychological sequelae and physical side effects associated with ADT. A secondary purpose was to examine the predictors of depression, anxiety and QoL in patients with PCa.",

author = "Chipperfield, {Kelly Maree} and Fletcher, {Jane Madeline} and Jeremy Millar and Brooker, {Joanne Elizabeth} and Robin Smith and Mark Frydenberg and Susan Burney",

year = "2013",

doi = "10.1002/pon.3269",

language = "English",

volume = "22",

pages = "2169 -- 2176",

journal = "Psycho-Oncology",

issn = "1057-9249",

publisher = "John Wiley & Sons",

number = "10",

}

TY - JOUR

T1 - Predictors of depression, anxiety and quality of life in patients with prostate cancer receiving androgen deprivation therapy

AU - Chipperfield, Kelly Maree

AU - Fletcher, Jane Madeline

AU - Millar, Jeremy

AU - Brooker, Joanne Elizabeth

AU - Smith, Robin

AU - Frydenberg, Mark

AU - Burney, Susan

PY - 2013

Y1 - 2013

N2 - To evaluate the effects of androgen deprivation therapy (ADT) on depression, anxiety and quality of life (QoL) in patients with prostate cancer (PCa) and to examine the relationship between meeting the National Physical Activity Guidelines of Australia (NPAGA) and the presence and severity of both psychological sequelae and physical side effects associated with ADT. A secondary purpose was to examine the predictors of depression, anxiety and QoL in patients with PCa.

AB - To evaluate the effects of androgen deprivation therapy (ADT) on depression, anxiety and quality of life (QoL) in patients with prostate cancer (PCa) and to examine the relationship between meeting the National Physical Activity Guidelines of Australia (NPAGA) and the presence and severity of both psychological sequelae and physical side effects associated with ADT. A secondary purpose was to examine the predictors of depression, anxiety and QoL in patients with PCa.

UR - http://onlinelibrary.wiley.com/doi/10.1002/pon.3269/pdf

U2 - 10.1002/pon.3269

DO - 10.1002/pon.3269

M3 - Article

SN - 1057-9249

VL - 22

SP - 2169

EP - 2176

JO - Psycho-Oncology

JF - Psycho-Oncology

IS - 10

ER -

Predictors of depression, anxiety and quality of life in patients with prostate cancer receiving androgen deprivation therapy

Abstract

UN SDGs

Access to Document

Other files and links

Cite this